There has been an in the increase use of Endometrial Ablation procedures over the past few years with an increase in the range of devices available to deliver the necessary energy together with the fact that there continues to be an increasing number of device-related adverse events reported to the MHRA Adverse Incident Centre.
It was for these reasons that the MHRA, with the support of the Royal College of Obstetricians and Gynaecologists (external link) and the British Society of Gynaecological Endoscopy (external link), set up a workshop with relevant manufacturers to discuss the various types of endometrial ablation devices, the different circumstances for use, the pros and cons of each technique, how to avoid adverse events and how to report these if they occur in relationship to the medical devices.
This guidance contains the conclusions of this joint workshop and sets out the responsibilities of the three parties involved: gynaecological clinicians, manufacturers and the regulator.
A paper copy of this document can be obtained from michael.peel@mhra.gsi.gov.uk
This guidance, along with other targeted information, can be found on our obstetrics and gynaecology page.
Guidance on the responsibilities of manufacturers, the regulator and clinicians with respect to endometrial ablation 
